PATIENT IDENTIFICATION

NEPHRONET HAS PARTNERED WITH ARKANA LABORATORIES TO IDENTIFY SUBJECTS AFTER A BIOPSY-PROVEN DIAGNOSIS.

Following a HIPPA compliant process, identified subjects will be referred to the closest trial site for enrollment. The entire process is tracked and metrics provided to sponsors. NephroNet works to provide patients with study referral options for numerous trials in nephrology. Please click on the link below to provide your information and someone will contact you with available clinical trial opportunities.